{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:05:45Z","timestamp":1782403545511,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteoarthritis is a destructive joint disease that leads to degeneration of cartilage and other morphological changes in the joint. No medical treatment currently exists that can reverse these morphological changes. Intra-articular injection with autologous, micro-fragmented adipose tissue has been suggested to relieve symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods\/Design<\/jats:title>\n                <jats:p>The study is a blinded randomized controlled trial with patients allocated in a 1:1 ratio to 2 parallel groups. Patients suffering from pain and functional impairment due to osteoarthritis Kellgren-Lawrence grades 2\u20133 in the tibiofemoral joint are eligible for inclusion. The intervention group is treated with an intra-articular injection with autologous, micro-fragmented adipose tissue prepared using the Lipogems\u00ae system. The control group receives an intra-articular injection with isotonic saline. In total, 120 patients are to be included.<\/jats:p>\n                <jats:p>The primary outcome is The Knee injury and Osteoarthritis Outcome Score (KOOS4) evaluated at 6 months. Secondary outcomes are KOOS at 3, 12 and 24 months; the Tegner activity score; treatment failure; and work status of the patient. The analysis will be conducted both as intention-to-treat and per-protocol analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This trial is the first to investigate the efficacy of autologous, micro-fragmented adipose tissue in a randomized controlled trial. The study uses the patient-reported outcome measure Knee Injury and Osteoarthritis Outcome Score (KOOS4) after 6 months as the primary outcome, as it is believed to be a valid measure to assess the patient\u2019s opinion about their knee and associated problems when suffering from osteoarthritis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-021-05628-4","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T07:03:38Z","timestamp":1635318218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Treatment of osteoarthritis with autologous, micro-fragmented adipose tissue: a study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"22","author":[{"given":"Rasmus Kramer","family":"Mikkelsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bl\u00f8nd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth Rosenkrantz","family":"H\u00f6lmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"M\u00f8lgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Troelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"H\u00f6lmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer Weisskirchner","family":"Barfod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"issue":"1","key":"5628_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1749-6632.2009.05240.x","volume":"1192","author":"MB Goldring","year":"2010","unstructured":"Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann. N. Y. Acad. Sci. 2010;1192(1):230\u20137. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05240.x.","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"5628_CR2","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/rheumatology\/kei049","volume":"44","author":"S Gupta","year":"2005","unstructured":"Gupta S, Hawker GA, Laporte A, Croxford R, Coyte PC. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology. 2005;44(12):1531\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/kei049.","journal-title":"Rheumatology"},{"issue":"4","key":"5628_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3111\/13696998.2011.594347","volume":"14","author":"M Gore","year":"2011","unstructured":"Gore M, Tai K-S, Sadosky A, Leslie D, Stacey BR. Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis. J. Med. Econ. 2011;14(4):497\u2013507. https:\/\/doi.org\/10.3111\/13696998.2011.594347.","journal-title":"J. Med. Econ."},{"key":"5628_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.joca.2011.01.021","volume":"19","author":"GA Hawker","year":"2011","unstructured":"Hawker GA, Mian S, Bednis K, Stanaitis I. Osteoarthritis year 2010 in review: non-pharmacologic therapy. Osteoarthr. Cartil. 2011;19:366\u201374.","journal-title":"Osteoarthr. Cartil"},{"key":"5628_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/194318","volume":"2014","author":"B Kristj\u00e1nsson","year":"2014","unstructured":"Kristj\u00e1nsson B, Honsawek S. Current perspectives in mesenchymal stem cell therapies for osteoarthritis. Stem Cells Int. 2014;2014:1\u201313. https:\/\/doi.org\/10.1155\/2014\/194318.","journal-title":"Stem Cells Int."},{"key":"5628_CR6","doi-asserted-by":"publisher","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143\u20137. https:\/\/doi.org\/10.1126\/science.284.5411.143.","DOI":"10.1126\/science.284.5411.143"},{"issue":"5","key":"5628_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3727\/000000004783983747","volume":"13","author":"S Wakitani","year":"2004","unstructured":"Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transpl. 2004;13(5):595\u2013600. https:\/\/doi.org\/10.3727\/000000004783983747.","journal-title":"Cell Transpl."},{"issue":"3","key":"5628_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1053\/joca.2001.0504","volume":"10","author":"S Wakitani","year":"2002","unstructured":"Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow-mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr. Cartil. 2002;10(3):199\u2013206. https:\/\/doi.org\/10.1053\/joca.2001.0504.","journal-title":"Osteoarthr. Cartil."},{"key":"5628_CR9","doi-asserted-by":"publisher","unstructured":"Michalek AJ, Moster R, Lukac L, Proefrock K. Autologous adipose tissue-derived stromal vascular fraction cells application in patients with osteoarthritis. Cell Transplant. 2015:1\u201336. https:\/\/doi.org\/10.3727\/096368915X686760.","DOI":"10.3727\/096368915X686760"},{"key":"5628_CR10","doi-asserted-by":"publisher","unstructured":"Wakitani S, Okabe T, Horibe S, Mitsuoka T, Saito M, Koyama T, et al. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J. Tissue Eng. Regen. Med. 2011;5(2):146\u201350. https:\/\/doi.org\/10.1002\/term.299.","DOI":"10.1002\/term.299"},{"issue":"3","key":"5628_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2217\/rme.10.37","volume":"5","author":"C Mason","year":"2010","unstructured":"Mason C, Manzotti E. Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010. Regen. Med. 2010;5(3):307\u201313. https:\/\/doi.org\/10.2217\/rme.10.37.","journal-title":"Regen. Med."},{"key":"5628_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2217\/rme.12.45","volume":"7","author":"EJ Culme-Seymour","year":"2012","unstructured":"Culme-Seymour EJ, Davie NL, Brindley DA, Edwards-Parton S, Mason C. A decade of cell therapy clinical trials (2000\u20132010). Regen. Med. 2012;7:455\u201362.","journal-title":"Regen. Med"},{"issue":"1","key":"5628_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/0363546516662455","volume":"45","author":"SA Shapiro","year":"2017","unstructured":"Shapiro SA, Kazmerchak SE, Heckman MG, Zubair AC, O\u2019Connor MI. A Prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am. J. Sports Med. 2017;45(1):82\u201390. https:\/\/doi.org\/10.1177\/0363546516662455.","journal-title":"Am. J. Sports Med."},{"issue":"1","key":"5628_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","volume":"9","author":"AI Caplan","year":"2011","unstructured":"Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9(1):11\u20135. https:\/\/doi.org\/10.1016\/j.stem.2011.06.008.","journal-title":"Cell Stem Cell"},{"key":"5628_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4702674","volume":"2016","author":"J Pak","year":"2016","unstructured":"Pak J, Lee JH, Kartolo WA, Lee SH. Cartilage regeneration in human with adipose tissue-derived stem cells: Current Status in Clinical Implications. Biomed Res. Int. 2016;2016:1\u201312. https:\/\/doi.org\/10.1155\/2016\/4702674.","journal-title":"Biomed Res. Int."},{"key":"5628_CR16","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1017\/erm.2014.9","volume":"16","author":"M Ruetze","year":"2014","unstructured":"Ruetze M, Richter W. Adipose-derived stromal cells for osteoarticular repair: trophic function versus stem cell activity. Expert Rev. Mol. Med. 2014;16:e9. https:\/\/doi.org\/10.1017\/erm.2014.9.","journal-title":"Expert Rev. Mol. Med."},{"issue":"1","key":"5628_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.stem.2008.11.012","volume":"4","author":"L \u00c4hrlund-Richter","year":"2009","unstructured":"\u00c4hrlund-Richter L, de Luca M, Marshak DR, Munsie M, Veiga A, Rao M. Isolation and production of cells suitable for human therapy: challenges ahead. Cell Stem Cell. 2009;4(1):20\u20136. https:\/\/doi.org\/10.1016\/j.stem.2008.11.012.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"5628_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s40778-016-0053-5","volume":"2","author":"C Tremolada","year":"2016","unstructured":"Tremolada C, Colombo V, Ventura C. Adipose tissue and mesenchymal stem cells: state of the art and Lipogems\u00ae technology development. Curr. Stem Cell Reports. 2016;2(3):304\u201312. https:\/\/doi.org\/10.1007\/s40778-016-0053-5.","journal-title":"Curr. Stem Cell Reports"},{"issue":"10","key":"5628_CR19","first-page":"pii:A5565","volume":"66","author":"KW Barfod","year":"2019","unstructured":"Barfod KW, Bl\u00f8nd L. Treatment of osteoarthritis with autologous and microfragmented adipose tissue. Dan Med J. 2019;66(10):pii:A5565.","journal-title":"Dan Med J"},{"key":"5628_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/01.bot.0000199119.38359.96","volume":"20","author":"EM Roos","year":"2006","unstructured":"Roos EM, Roos HP, Lohmander LS. Knee Injury and Osteoarthritis Outcome Score (KOOS). J. Orthop. Trauma. 2006;20 Supplem:89\u201392.","journal-title":"J. Orthop. Trauma"},{"key":"5628_CR21","doi-asserted-by":"publisher","unstructured":"Roos, E. M. Knee injury and Osteoarthritis Outcome Score (KOOS) User\u2019s Guide 1.1 Updated August 2012. KOOS.NU (2012). doi:https:\/\/doi.org\/10.1097\/00005131-200609001-00018","DOI":"10.1097\/00005131-200609001-00018"},{"issue":"2","key":"5628_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2519\/jospt.1998.28.2.88","volume":"28","author":"EM Roos","year":"1998","unstructured":"Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure. J. Orthop. Sports Phys. Ther. 1998;28(2):88\u201396. https:\/\/doi.org\/10.2519\/jospt.1998.28.2.88.","journal-title":"J. Orthop. Sports Phys. Ther."},{"key":"5628_CR23","unstructured":"KOOS.NU. (2015). Available at: www.koos.nu."},{"issue":"4","key":"5628_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1056\/NEJMoa0907797","volume":"363","author":"RB Frobell","year":"2010","unstructured":"Frobell RB, Roos EM, Roos HP, Ranstam J, Lohmander LS. A randomized trial of treatment for acute anterior cruciate ligament tears. N. Engl. J. Med. 2010;363(4):331\u201342. https:\/\/doi.org\/10.1056\/NEJMoa0907797.","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"5628_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1477-7525-1-64","volume":"1","author":"EM Roos","year":"2003","unstructured":"Roos EM, Lohmander LS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual. Life Outcomes. 2003;1(1):64. https:\/\/doi.org\/10.1186\/1477-7525-1-64.","journal-title":"Health Qual. Life Outcomes"},{"issue":"198","key":"5628_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00003086-198509000-00007","volume":"198","author":"Y Tegner","year":"1985","unstructured":"Tegner Y, Lysholm J. Rating systems in the evaluation of knee ligament injuries. Clin Orthop Relat Res. 1985;198(198):43\u20139. https:\/\/doi.org\/10.1097\/00003086-198509000-00007.","journal-title":"Clin Orthop Relat Res."},{"issue":"2","key":"5628_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, JG. Conde, Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform."},{"key":"5628_CR28","doi-asserted-by":"publisher","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","DOI":"10.1016\/j.jbi.2019.103208"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05628-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05628-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05628-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T07:06:46Z","timestamp":1635318406000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05628-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5628"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05628-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"16 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained on the 9th of September 2018 and approval of amendments was obtained the 9th of November 2018 from the Ethical Review Board of the Capital Region of Denmark, identifier H-18013145.The study is carried out in accordance with the principles of the Helsinki Declaration. Patients are covered by the patient insurance of Copenhagen University Hospital Hvidovre and Zealand University hospital.All patients will receive verbal and written information concerning the study. The inclusion will take place after a declaration of consent has been obtained. It is the responsibility of the investigator to provide patients with comprehensive verbal and written information of the study, purpose, and potential risks and benefits. Upon inclusion of the patient, he\/she will be informed of the scientific aspects of the study. The verbal information follows the content of the written information, which will be reviewed together with the patient where specific content will be elaborated if needed. The verbal information will be tailored according to age, socio-economic status and education of the patient. The investigator in question will ensure that the patient is thoroughly informed. The verbal information is given in undisturbed conditions at a scheduled time in the outpatient orthopaedic clinic. The project manager must ensure that the investigator or other authorized person who is presenting a patient with information is thoroughly informed of the project and professionally qualified to provide information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Model consent form and other related documentation given to the participants and authorized surrogates.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"Lipogems\u00ae has contributed significantly to the study. The equipment from Lipogems\u00ae is delivered free of charge by the company. The company also contributed to the training of the surgeons prior to the start. Lipogems\u00ae was not contacted until after the study had been designed and the first approval was granted by the National Ethics Committee. The company has had no influence on the study design or writing of the protocol. The research team has the rights to all data, analysis of the data and final publication. Lipogems\u00ae have no rights and\/ or decisions in regard to the publication of the results.None of the investigators have financial or other interests in relation to the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"748"}}